In Brief
This article was originally published in The Rose Sheet
Executive Summary
FDA Urges Public: Report Bad Reactions To Cosmetics
You may also be interested in...
With AE Reporting Push, FDA Emphasizes Importance Of Cosmetic Safety
FDA hopes a campaign promoting its adverse event reporting program for cosmetics will lead to increased consumer participation, which could put further pressure on industry to ensure the safety of their products.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.